Importantly, this study sheds light on a novel mechanism through which TNBC cells exploit the CD155/TIGIT axis to rewire CD8 + T cell metabolism, thus creating an immunosuppressive milieu that supports tumor progression. This evidence concerns the gene CD8A and neoplasm.